Unphosphorylated STAT1 Promotes Sarcoma Development through Repressing Expression of Fas and Bad and Conferring Apoptotic Resistance
- 15 September 2012
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 72 (18) , 4724-4732
Abstract
STAT1 exists in phosphorylated (pSTAT1) and unphosphorylated (uSTAT1) forms each regulated by IFN-γ. Although STAT1 is a key mediator of the IFN-γ signaling pathway, an essential component of the host cancer immunosurveillance system, STAT1 is also overexpressed in certain human cancers where the functions of pSTAT1 and uSTAT1 are ill defined. Using a murine model of soft tissue sarcoma (STS), we show that disruption of the IFN effector molecule IRF8 decreases pSTAT1 and increases uSTAT1 in STS cells, thereby increasing their metastatic potential. We determined that the IRF8 gene promoter was hypermethylated frequently in human STS. An analysis of 123 human STS specimens revealed that high uSTAT1 levels in tumor cells was correlated with a reduction in disease-specific survival (DSS), whereas high pSTAT1 levels in tumor cells were correlated with an increase in DSS. In addition, uSTAT1 levels were negatively correlated with pSTAT1 levels in these STS specimens. Mechanistic investigations revealed that IRF8 suppressed STAT1 transcription by binding the STAT1 promoter. RNAi-mediated silencing of STAT1 in STS cells was sufficient to increase expression of the apoptotic mediators Fas and Bad and to elevate the sensitivity of STS cells to Fas-mediated apoptosis. Together, our findings show how the phosphorylation status of pSTAT1 determines its function as a tumor suppressor, with uSTAT1 acting as a tumor promoter that acts by elevating resistance to Fas-mediated apoptosis to promote immune escape. Cancer Res; 72(18); 4724–32. ©2012 AACR.Keywords
All Related Versions
This publication has 50 references indexed in Scilit:
- Identification and validation of genes involved in cervical tumourigenesisBMC Cancer, 2011
- Intratumoral T cell infiltration, MHC class I and STAT1 as biomarkers of good prognosis in colorectal cancerGut, 2010
- Role of apoptosis resistance in immune evasion and metastasis of colorectal cancerWorld Journal of Gastrointestinal Oncology, 2010
- STAT1-dependent expression of energy metabolic pathways links tumour growth and radioresistance to the Warburg effectBMC Medicine, 2009
- Identification of novel epigenetically modified genes in human melanoma via promoter methylation gene profilingPigment Cell & Melanoma Research, 2008
- Downregulation of IFN-γR in association with loss of Fas function is linked to tumor progressionInternational Journal of Cancer, 2007
- Cutting Edge: In Contrast to Effector T Cells, CD4+CD25+FoxP3+ Regulatory T Cells Are Highly Susceptible to CD95 Ligand- but Not to TCR-Mediated Cell DeathThe Journal of Immunology, 2005
- STAT1Cancer Research, 2004
- Stat1-dependent and -independent pathways in IFN-γ-dependent signalingTrends in Immunology, 2002
- Fas and Fas Ligand Interactions Suppress Melanoma Lung MetastasisJournal of Experimental Medicine, 1998